advertisement
Grauslund J 9
Showing records 1 to 9 | Display all abstracts from Grauslund J106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Sperling S
Acta Ophthalmologica 2023; 101: 384-391
105961 Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Floaters: A Systematic Review with Meta-Analyses
Dysager DD; Koren SF
Ophthalmology and therapy 2022; 11: 2225-2242
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Stokholm L
Acta Ophthalmologica 2023; 101: 384-391
105961 Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Floaters: A Systematic Review with Meta-Analyses
Grauslund J
Ophthalmology and therapy 2022; 11: 2225-2242
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Thykjaer AS; Pedersen FN
Acta Ophthalmologica 2023; 101: 384-391
105961 Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Floaters: A Systematic Review with Meta-Analyses
Wied J
Ophthalmology and therapy 2022; 11: 2225-2242
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Möller S
Acta Ophthalmologica 2023; 101: 384-391
105961 Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Floaters: A Systematic Review with Meta-Analyses
Subhi Y
Ophthalmology and therapy 2022; 11: 2225-2242
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Laugesen CS; Andersen N; Andresen J; Bek T; la Cour M; Hajari J; Heegaard S; Højlund K; Kawasaki R; Kolko M; Schielke KC; Rubin KH; Vestergaard AH; Grauslund J
Acta Ophthalmologica 2023; 101: 384-391
